Accessibility StatementSkip Navigation NEW YORK, Sept. 29, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Fluor Corporation (NYSE: FLR). Shareholders who purchased shares of FLR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE:https://securitiesclasslaw.com/securities/fluor-corporation-loss-submission-form/? id=16961 ...

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of KBR, Inc. regarding a class action lawsuit alleging that the company made materially false and misleading statements about its business operations and prospects during a specific class period [1]. Group 1: Allegations and Class Period - The class period for the allegations is from May 6, 2025, to June 19, 2025 [1]. - The complaint claims that KBR's management misrepresented the status of its partnership with the U.S. Department of Defense's Transportation Command, despite knowing about significant concerns regarding HomeSafe's ability to fulfill a global household goods contract [1]. - As a result of these misrepresentations, statements made by KBR regarding its business and operational prospects were deemed materially false and misleading [1]. Group 2: Next Steps for Shareholders - Shareholders who purchased KBR shares during the specified class period are encouraged to register for the class action by November 18, 2025 [2]. - Upon registration, shareholders will be enrolled in a portfolio monitoring system to receive updates on the case's progress [2]. - There is no cost or obligation for shareholders to participate in the case [2]. Group 3: Law Firm's Mission - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit, fraud, and illegal business practices [3]. - The firm aims to ensure that companies adhere to responsible business practices and seeks recovery for investors who have suffered losses due to misleading statements or omissions [3].

Core Viewpoint - The Gross Law Firm has announced a class action lawsuit against Semler Scientific, Inc. (NASDAQ: SMLR) for allegedly issuing materially false and misleading statements during the class period from March 10, 2021, to April 15, 2025, including failing to disclose a significant investigation by the U.S. Department of Justice regarding violations of the False Claims Act [1]. Group 1: Allegations and Class Period - The class period for the lawsuit is defined as March 10, 2021, to April 15, 2025 [1]. - Allegations include that Semler Scientific did not disclose a material investigation by the U.S. Department of Justice into violations of the False Claims Act, while discussing potential violations in hypothetical terms [1]. Group 2: Shareholder Actions - Shareholders who purchased shares of SMLR during the specified class period are encouraged to contact the Gross Law Firm for possible lead plaintiff appointment [1]. - The deadline for shareholders to register for the class action and seek lead plaintiff status is October 28, 2025 [2]. - Once registered, shareholders will be enrolled in a portfolio monitoring software to receive updates throughout the case lifecycle [2]. Group 3: Firm's Mission and Commitment - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors affected by deceit, fraud, and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions of material information [3].

Core Viewpoint - The Gross Law Firm has announced a class action lawsuit on behalf of shareholders of Lineage, Inc. (NASDAQ: LINE), alleging that the company made materially false and misleading statements regarding its financial health and operational performance during the class period surrounding its IPO on July 26, 2024 [1][2][3]. Allegations - The lawsuit claims that Lineage experienced a significant decline in customer demand due to increased cold-storage supply and a destocking of excess inventory by customers, which was a response to changing consumer trends post-COVID-19 [3]. - It is alleged that Lineage implemented unsustainable price increases prior to the IPO, which could not be maintained in the face of weakening demand [3]. - The company reportedly failed to counteract adverse trends through operational efficiencies or competitive advantages, leading to stagnant or declining revenue, occupancy rates, and rent prices, contrary to the representations made in the registration statement [3]. - As a result of these issues, Lineage's financial results and business prospects were materially impaired, contradicting the claims of stable revenue growth and high occupancy rates [3]. Next Steps for Shareholders - Shareholders who purchased shares of Lineage during the specified class period are encouraged to register for the class action by September 30, 2025, to potentially be appointed as lead plaintiffs [4]. - Registration will provide shareholders with updates throughout the lifecycle of the case, and participation in the case incurs no cost or obligation [4]. Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors who have suffered losses due to deceitful practices by companies [5].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of PubMatic, Inc. regarding a class action lawsuit due to allegations of misleading statements and failure to disclose significant changes affecting the company's revenue and operations [1]. Group 1: Allegations and Impact - The complaint alleges that during the class period from February 27, 2025, to August 11, 2025, PubMatic's management made materially false and misleading statements [1]. - A top demand side platform buyer shifted a significant number of clients to a new platform, which evaluated inventory differently, leading to a reduction in ad spend and revenue for PubMatic [1]. - As a result of these changes, the positive statements made by the defendants regarding the company's business and prospects were deemed materially misleading and lacked a reasonable basis [1]. Group 2: Class Action Details - Shareholders who purchased shares of PUBM during the specified class period are encouraged to register for the class action, with a deadline set for October 20, 2025 [2]. - Once registered, shareholders will be enrolled in a portfolio monitoring software to receive updates throughout the lifecycle of the case [2]. - There is no cost or obligation for shareholders to participate in this case [2]. Group 3: Law Firm's Mission - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors who have suffered due to deceit, fraud, and illegal business practices [3]. - The firm aims to ensure that companies adhere to responsible business practices and seeks recovery for investors who incurred losses from misleading statements or omissions that led to artificial inflation of stock prices [3].

Core Viewpoint - Altimmune, Inc. (NASDAQ: ALT) faces a class action lawsuit following the announcement of disappointing results from its IMPACT Phase 2b MASH trial, leading to a significant drop in stock price [1]. Group 1: Company Performance - On June 26, 2025, Altimmune reported topline results from the IMPACT Phase 2b MASH trial of Pemvidutide, which failed to achieve statistical significance in the primary endpoint of fibrosis reduction [1]. - The stock price of Altimmune plummeted from $7.71 per share on June 25, 2025, to $3.61 per share on June 26, 2025, marking a decline of 53.2% in just one day [1]. Group 2: Legal Proceedings - Shareholders who purchased shares of ALT between August 10, 2023, and June 25, 2025, are encouraged to register for the class action lawsuit, with a deadline for lead plaintiff appointment set for October 6, 2025 [2]. - The Gross Law Firm is leading the class action, aiming to protect investors who suffered losses due to misleading statements from the company [3].

Shareholders who purchased shares of DOW during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/dow-inc-loss-submission-form/?id=168874&from=4 CLASS PERIOD: January 30, 2025 to July 23, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements a ...

Core Viewpoint - C3.ai, Inc. is facing a class action lawsuit due to allegations of providing misleading statements about its growth and the impact of its CEO's health on the company's performance, leading to a significant drop in stock price following disappointing financial results [1]. Group 1: Allegations and Impact - The lawsuit claims that C3.ai's management made overly positive statements while concealing material adverse facts about the company's growth potential and the CEO's health issues [1]. - On August 8, 2025, C3.ai announced disappointing preliminary financial results for Q1 of fiscal 2026 and reduced its revenue guidance for the full fiscal year 2026, attributing the poor performance to "the reorganization with new leadership" and the CEO's health [1]. - Following the announcement, C3.ai's stock price plummeted from $22.13 per share to $16.47 per share, marking a decline of approximately 25.58% in just one day [1]. Group 2: Class Action Details - Shareholders who purchased shares of C3.ai during the class period from February 26, 2025, to August 8, 2025, are encouraged to register for the class action lawsuit [2]. - The deadline for shareholders to seek lead plaintiff status is October 21, 2025, and there is no cost or obligation to participate in the case [2].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of LifeMD, Inc. regarding a class action lawsuit due to allegations of materially false and misleading statements made by the company during the specified class period [1]. Summary by Relevant Sections Allegations - The complaint alleges that during the class period from May 7, 2025, to August 5, 2025, LifeMD's management overstated the company's competitive position [1]. - It is claimed that the company was reckless in raising its 2025 guidance without properly accounting for rising customer acquisition costs in its RexMD segment and related to obesity treatment drugs like Wegovy and Zepbound [1]. - As a result, the statements made by the defendants regarding LifeMD's business, operations, and prospects were materially false and misleading [1]. Class Action Details - Shareholders who purchased shares of LifeMD during the class period are encouraged to register for the class action, with a deadline set for October 25, 2025 [2]. - Once registered, shareholders will be enrolled in a portfolio monitoring software to receive updates throughout the case lifecycle [2]. Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors who have suffered losses due to deceit, fraud, and illegal business practices [3]. - The firm aims to ensure that companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements that led to artificial inflation of stock prices [3].

Core Viewpoint - Nutex Health Inc. is facing allegations of issuing materially false and misleading statements during the class period from August 8, 2024, to August 14, 2025, which has led to a class action lawsuit against the company [1]. Summary by Sections Allegations - The complaint alleges that Nutex Health engaged in a coordinated scheme to defraud insurance companies through its third-party vendor HaloMD, resulting in unsustainable revenues [1]. - The company overstated its ability to remediate material weaknesses in its internal controls over financial reporting, leading to improper accounting of stock-based compensation obligations [1]. - Nutex misclassified stock-based compensation obligations as equity instead of liabilities, increasing the risk of failing to file financial reports with the SEC on time [1]. - The allegations suggest that Nutex's business and financial prospects were overstated, making public statements materially false and misleading [1]. Class Action Details - Shareholders who purchased shares of Nutex during the specified class period are encouraged to register for the class action, with a deadline for lead plaintiff appointment set for October 21, 2025 [2]. - Registered shareholders will receive updates through a portfolio monitoring software throughout the lifecycle of the case [2]. Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [3].